About
Glycologix is a clinical-stage biotechnology company developing locally delivered biopolymers designed to protect and repair soft tissues, with a lead therapy targeting interstitial cystitis/bladder pain syndrome.
Explore Glycologix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.